Stapokibart shows promise in reducing nasal congestion in seasonal allergy patients, study finds

The efficacy and safety of stapokibart as an in patients with seasonal allergic rhinitis (SAR).

Gene Therapy May Cure More Rare Diseases, but Drugmakers Have Few Incentives

Robin Alderman faces an agonizing reality: Gene therapy might cure her son Camden’s rare, inherited immune deficiency. But it’s not available to him. In 2022,

June 22, 2024

Marinomed Biotech AG evaluates strategic options for Carragelose portfolio – Biotech Investments

EQS-News: Marinomed Biotech AG / Key word(s): Strategic Company Decision Marinomed Biotech AG evaluates strategic options for Carragelose portfolio 18.12.2023 / 08:33 CET/CEST The issuer

December 19, 2023

EC approves Bristol Myers Squibb’s Reblozyl for MDS treatment

Share this article The approval for Bristol Myers Squibb’s Reblozyl is applicable in all the EU member states. Katherine Welles / Shutterstock.com. The European Commission

April 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.